West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
337.32
-8.77 (-2.53%)
Aug 28, 2026, 4:00 PM EDT - Market closed
WST Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,327 | 3,074 | 2,893 | 2,950 | 2,887 | 2,832 |
Revenue Growth | 12.38% | 6.25% | -1.92% | 2.18% | 1.95% | 31.89% |
Gross Profit Gross Profit Growth | 1,224 | 1,104 | 998.5 | 1,130 | 1,136 | 1,178 |
Operating Income Operating Income Growth | 730.8 | 638.7 | 593.6 | 706.2 | 763.8 | 768.6 |
Net Income Net Income Growth | 564.9 | 493.7 | 492.7 | 593.4 | 585.9 | 661.8 |
Earnings Per Share EPS Growth | 7.81 | 6.79 | 6.69 | 7.88 | 7.73 | 8.67 |
EPS Growth | 16.82% | 1.49% | -15.10% | 1.94% | -10.84% | 89.72% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Proprietary Products Proprietary Products Growth | 2,726 | 2,492 | 2,335 | 2,397 | 2,407 | 2,317 |
West Vantage Products West Vantage Products Growth | 600.6 | 582 | 558.7 | 552.5 | 480.4 | 514.7 |
Revenue (Total) Revenue (Total) Growth | 3,327 | 3,074 | 2,893 | 2,950 | 2,887 | 2,832 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 435.8 | 791.3 | 484.6 | 853.9 | 894.3 | 762.6 |
Total Debt Total Debt Growth | 316.5 | 326.2 | 305.3 | 309 | 317.9 | 325.3 |
Net Cash (Debt) Net Cash Growth | 119.3 | 465.1 | 179.3 | 544.9 | 576.4 | 437.3 |
Net Cash Growth | -40.79% | 159.40% | -67.09% | -5.46% | 31.81% | 53.87% |
Net Cash Per Share Net Cash Per Share Growth | 1.65 | 6.40 | 2.43 | 7.24 | 7.60 | 5.73 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 662.2 | 754.8 | 653.4 | 776.5 | 724 | 584 |
Capital Expenditures CapEx Growth | -225.3 | -285.9 | -377 | -362 | -284.6 | -253.4 |
Free Cash Flow Free Cash Flow Growth | 436.9 | 468.9 | 276.4 | 414.5 | 439.4 | 330.6 |
Free Cash Flow Growth | 27.01% | 69.64% | -33.32% | -5.67% | 32.91% | 10.90% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 36.79% | 35.91% | 34.51% | 38.31% | 39.36% | 41.59% |
Operating Margin | 21.97% | 20.78% | 20.52% | 23.94% | 26.46% | 27.14% |
Pretax Margin | 21.31% | 20.02% | 20.75% | 24.26% | 24.27% | 27.16% |
Profit Margin | 16.98% | 16.06% | 17.03% | 20.12% | 20.29% | 23.37% |
FCF Margin | 13.13% | 15.25% | 9.55% | 14.05% | 15.22% | 11.68% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.880 | 0.850 | 0.810 | 0.770 | 0.730 | 0.690 |
Dividend Per Share Growth | 4.76% | 4.94% | 5.20% | 5.48% | 5.80% | 6.15% |
Dividend Yield | 0.26% | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 43.19 | 40.09 | 48.15 | 43.91 | 29.74 | 52.50 |
Forward PE | 36.37 | 36.69 | 45.90 | 42.23 | 34.84 | 53.55 |
P/FCF Ratio | 54.52 | 42.22 | 85.83 | 62.86 | 39.65 | 105.09 |
PS Ratio | 7.16 | 6.44 | 8.20 | 8.83 | 6.04 | 12.27 |